Latest IR information
IR News
- 2024.10.31
- Summary of Consolidated Financial Statements for the First Nine Months of Fiscal Year Ending December 31, 2024 [Japanese GAAP]
- 2024.10.23
- SymBio presents data from Phase IIa clinical trial showing clinical efficacy of IV BCV in treating symptoms of adenovirus infection
- 2024.09.30
- SymBio Reaches Settlement Agreement in Patent Infringement Litigation Related to TREAKISYM
- 2024.08.19
- SymBio Initiates Phase 1b Clinical Trial of IV Brincidofovir in Patients with Lymphoma as a First in Human Study for Oncology
- 2024.08.01
- Summary of Consolidated Financial Statements for the First Six Months of Fiscal Year Ending December 31, 2024 [Japanese GAAP]